Evidence map›Paper›PMID 25429139›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Poly(ADP-ribose) polymerase-1 causes mitochondrial damage and neuron death mediated by Bnip3.

Ping Lu, Amit Kamboj, Spencer B Gibson, Christopher M Anderson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Alterations ofCurrent Alzheimer research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. The role of Foxo3a in neuron-mediated cognitive impairment.Frontiers in molecular neuroscience · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Epithelial NADFrontiers in immunology · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ping LuNeuroscience Research Program, Kleysen Institute for Advanced Medicine, Winnipeg Health Sciences Centre and College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0Z3, Canada, Department of Pharmacology and Therapeutics, College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada, and.
Amit KambojNeuroscience Research Program, Kleysen Institute for Advanced Medicine, Winnipeg Health Sciences Centre and College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0Z3, Canada, Department of Pharmacology and Therapeutics, College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada, and.
Spencer B GibsonManitoba Institute of Cell Biology, Winnipeg, Manitoba R3E 0T3, Canada.
Christopher M AndersonNeuroscience Research Program, Kleysen Institute for Advanced Medicine, Winnipeg Health Sciences Centre and College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0Z3, Canada, Department of Pharmacology and Therapeutics, College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada, and chris.anderson@med.umanitoba.ca.
University of Manitoba · CAHealth Sciences Centre · CAResearch Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive pathophysiological activity of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP1) causes neuron death in brain hypoxia/ischemia by inducing mitochondrial permeability transition and nuclear translocation of apoptosis-inducing factor (AIF). Bcl-2/adenovirus E1B 19 kDa-interacting protein (Bnip3) is a prodeath BH3-only Bcl-2 protein family member that is induced in hypoxia, and has effects on mitochondrial permeability and neuronal survival similar to those caused by PARP1 activation. We hypothesized that Bnip3 is a critical mediator of PARP1-induced mitochondrial dysfunction and neuron death. Hypoxic death of mouse cortical neuron cultures was mitigated by deletion of either PARP1 or Bnip3, indicating that both factors are involved. Direct normoxic PARP1 activation by a DNA alkylating agent enhanced Bnip3 expression, and caused Bnip3-dependent mitochondrial membrane permeability, AIF translocation, and neuron death. Hypoxia produced PARP1-dependent depletion of nicotinamide adenine dinucleotide (NAD(+)) and inhibition of the NAD(+)-dependent class III histone deactelyase (HDAC) sirtuin-1 (SIRT1). This, in turn, led to hyperacetylation and nuclear localization of the forkhead box (Fox) protein FoxO3a, followed by enhanced association of FoxO3a with the Bnip3 upstream promoter region, increased levels of Bnip3 transcript, and elevated mitochondrial Bnip3 immunoreactivity. Finally, FoxO3a silencing using a lentiviral short hairpin RNA approach significantly reduced hypoxic Bnip3 expression, mitochondrial damage, and neuron death. Together, these data illustrate a direct PARP1-mediated hypoxic signaling pathway involving NAD(+) depletion, SIRT1 inhibition, FoxO3a-driven Bnip3 generation, and mitochondrial AIF release.

Indexed as

AnimalsCell DeathCells, CulturedFemaleMaleMembrane ProteinsMiceMice, 129 StrainMice, KnockoutMitochondriaMitochondrial ProteinsNeuronsPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesBNip3 protein, mouseMembrane ProteinsMitochondrial ProteinsParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerasesapoptosis-inducing factorBnip3ischemiamitochondrial permeabilityPARPsirtuin

Identifiers

PMID25429139
PMCPMC6608475
OpenAlexW2021073550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.